article thumbnail

Scaling: The Problem of More

Harvard Business Review

Back in 2011, in Citrus Lane’s first six months, its small founding team worked in a house and ate lunch together every day around a big table. We studied how Wyeth, the large Pharmaceutical firm (now part of Pfizer) made dramatic improvements in cost and quality across its manufacturing operation. After raising $5.1

article thumbnail

Using Supply Chains to Grow Your Business

Harvard Business Review

Compliance is crucial for pharmaceutical makers such as Abbott and Amgen – a “ Form 483 ” warning from an FDA inspector can shut down a drug facility in an instant and even land top executives in jail. In 2011, Havens’ collaboration with IBM procurement paid off, winning Havens four significant projects.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

3 Health Care Trends That Don’t Hinge on the ACA

Harvard Business Review

In 2004 one in 5 practicing physicians used an electronic health record (EHR) in the U.S. In 2011 81 digital health startups received venture funding; with consistent year-over-year increases, 296 startups were venture backed in 2016. Today nearly nine in 10 physicians regularly employ EHRs.

article thumbnail

U.S. Corporations Don’t Need Tax Breaks on Foreign Profits

Harvard Business Review

corporations responded by bringing back $299 billion in profits in 2005, compared with an average of $62 billion from 2000 to 2004 and a subsequent decline to $102 billion in 2006. Which brings us back to Pfizer, the pharmaceutical drug company that has provoked the new round of patriotic denunciations of corporate tax flight.

Hedge 8